Advertisement

Topics

Cardiac Radiation Dose in NSCLC Predicts Mortality, Cardiac AEs

08:00 EDT 14 Jun 2019 | Drugs.com

FRIDAY, June 14, 2019 -- Cardiac radiation dose exposure is a modifiable cardiac risk factor for major adverse cardiac events (MACE) and all-cause mortality (ACM) in patients with non-small cell lung cancer (NSCLC), according to a study published in...

Original Article: Cardiac Radiation Dose in NSCLC Predicts Mortality, Cardiac AEs

NEXT ARTICLE

More From BioPortfolio on "Cardiac Radiation Dose in NSCLC Predicts Mortality, Cardiac AEs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Gilotrif (afatinib)
GILOTRIF (afatinib) is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L8...